World's Best Scientists 2026 revealed!
Allison L. Naleway

Allison L. Naleway

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Microbiology 69 2034 1857 859 760 306 17792

Allison L. Naleway publications per year

The chart shows the history of publications by Allison L. Naleway between 2002 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Allison L. Naleway published across 25 years, from 2002 to 2026, averaging 14.2 papers a year. Output peaked at 41 publications in 2022. 37 of the 356 publications appeared in the last two years.

No. of publications
10 20 30 40
Bar chart. Horizontal axis: year, 2002 to 2026. Vertical axis: number of publications, 0 to 41. Peak 41 publications in 2022. 2002: 4 publications 2003: 2 publications 2004: 1 publication 2005: 5 publications 2006: 4 publications 2007: 0 publications 2008: 2 publications 2009: 8 publications 2010: 3 publications 2011: 9 publications 2012: 9 publications 2013: 24 publications 2014: 17 publications 2015: 22 publications 2016: 11 publications 2017: 17 publications 2018: 19 publications 2019: 14 publications 2020: 9 publications 2021: 32 publications 2022: 41 publications 2023: 39 publications 2024: 27 publications 2025: 32 publications 2026: 5 publications
2002 2026

356 publications in total across all disciplines

View publications per year as a table
Allison L. Naleway: publications per year, 2002 to 2026
Year Publications
2002 4
2003 2
2004 1
2005 5
2006 4
2007 0
2008 2
2009 8
2010 3
2011 9
2012 9
2013 24
2014 17
2015 22
2016 11
2017 17
2018 19
2019 14
2020 9
2021 32
2022 41
2023 39
2024 27
2025 32
2026 5
Total 356
Download as CSV

Allison L. Naleway publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Allison L. Naleway sits on this spectrum.

No. of scientists
50 100 150 200 250
Bar chart with 64 bars. Horizontal axis: publications, 55–64 to 679+. Vertical axis: number of scientists, 0 to 288. Most scientists, 288, have 135–144 publications. The last bar groups every scientist with 679 publications or more. The highlighted bar, 305–314 publications, is where this scientist sits. 55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55–64 publications 679+

This scientist: 306 publications — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

View publications distribution as a table
Number of Microbiology scientists by publication count, Research.com 2026 ranking edition. Based on 5,513 ranked scientists.
Publications Scientists This scientist
55–64 8
65–74 29
75–84 55
85–94 112
95–104 137
105–114 190
115–124 235
125–134 234
135–144 288
145–154 265
155–164 264
165–174 253
175–184 276
185–194 190
195–204 234
205–214 208
215–224 198
225–234 155
235–244 161
245–254 160
255–264 146
265–274 139
275–284 148
285–294 115
295–304 96
305–314 88 306
315–324 106
325–334 65
335–344 76
345–354 64
355–364 62
365–374 65
375–384 61
385–394 34
395–404 44
405–414 36
415–424 35
425–434 29
435–444 33
445–454 34
455–464 25
465–474 26
475–484 20
485–494 19
495–504 16
505–514 17
515–524 23
525–534 14
535–544 14
545–554 18
555–564 12
565–574 7
575–584 9
585–594 9
595–604 9
605–614 7
615–624 9
625–634 7
635–644 4
645–654 5
655–664 6
665–674 7
675–678 3
679+ 99
Download as CSV

Allison L. Naleway D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Allison L. Naleway sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 88 bars. Horizontal axis: D-Index, 40 to 127+. Vertical axis: number of scientists, 0 to 162. Most scientists, 162, have 58 D-Index. The last bar groups every scientist with 127 D-Index or more. The highlighted bar, 69 D-Index, is where this scientist sits. 40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 69 D-Index — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

View D-Index distribution as a table
Number of Microbiology scientists by D-index, Research.com 2026 ranking edition. Based on 5,513 ranked scientists.
D-Index Scientists This scientist
40 30
41 86
42 90
43 117
44 122
45 123
46 108
47 110
48 106
49 109
50 129
51 111
52 116
53 127
54 134
55 134
56 112
57 136
58 162
59 151
60 139
61 123
62 126
63 144
64 109
65 103
66 124
67 112
68 103
69 131 69
70 94
71 93
72 96
73 92
74 80
75 66
76 87
77 60
78 73
79 59
80 57
81 55
82 47
83 77
84 50
85 45
86 42
87 41
88 32
89 38
90 35
91 34
92 27
93 26
94 33
95 22
96 37
97 22
98 21
99 22
100 30
101 16
102 20
103 17
104 19
105 16
106 19
107 18
108 14
109 10
110 9
111 7
112 11
113 6
114 15
115 10
116 12
117 7
118 10
119 10
120 11
121 2
122 7
123 12
124 5
125 9
126 6
127+ 95
Download as CSV

Overview

Allison L. Naleway is affiliated with Kaiser Permanente in the United States and has made significant contributions primarily within the field of Medicine. The focus of their research includes multiple subfields such as Infectious Diseases, Epidemiology, Health, Obstetrics and Gynecology, and Public Health, Environmental and Occupational Health.

Their work covers a range of main topics including:

  • Vaccine Coverage and Hesitancy
  • SARS-CoV-2 and COVID-19 Research
  • Influenza Virus Research Studies
  • Respiratory Viral Infections Research
  • COVID-19 Clinical Research Studies
  • COVID-19 Impact on Reproduction
  • Viral Gastroenteritis Research and Epidemiology

Several notable papers by Allison L. Naleway include:

  • Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers - Eight U.S. Locations, December 2020-March 2021, 2021, MMWR Morbidity and Mortality Weekly Report
  • Surveillance for Adverse Events After COVID-19 mRNA Vaccination, 2021, JAMA
  • Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines, 2021, New England Journal of Medicine
  • Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings, 2021, New England Journal of Medicine
  • Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022, 2022, MMWR Morbidity and Mortality Weekly Report

Their frequent coauthors include:

  • Stephanie A. Irving
  • Nicola P. Klein
  • Manjusha Gaglani
  • Ousseny Zerbo
  • Malini B. DeSilva

Allison L. Naleway has published extensively in several key venues with the highest number of publications appearing in:

  • MMWR Morbidity and Mortality Weekly Report
  • Vaccine
  • Open Forum Infectious Diseases
  • Clinical Infectious Diseases
  • bioRxiv (Cold Spring Harbor Laboratory)

Best Publications

  • Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022

    Unknown

  • Surveillance for Adverse Events After COVID-19 mRNA Vaccination.

    Nicola P Klein;Ned Lewis;Kristin Goddard;Bruce Fireman

  • Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.

    Mark G Thompson;Jefferey L Burgess;Allison L Naleway;Harmony Tyner

  • Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings.

    Mark G Thompson;Edward Stenehjem;Shaun Grannis;Sarah W Ball

  • Measles-Mumps-Rubella-Varicella Combination Vaccine and the Risk of Febrile Seizures

    Nicola P. Klein;Bruce Fireman;W. Katherine Yih;Edwin Lewis

  • The Vaccine Safety Datalink: A Model for Monitoring Immunization Safety

    James Baggs;Julianne Gee;Edwin Lewis;Gabrielle Fowler

  • Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022

    Unknown

  • Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink.

    Julianne Gee;Allison Naleway;Irene Shui;James Baggs

  • Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022

    Unknown

  • Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study

    Unknown

  • Risk of Intussusception after Monovalent Rotavirus Vaccination

    Eric S. Weintraub;James Baggs;Jonathan Duffy;Claudia Vellozzi

  • The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety

    Michael M. McNeil;Julianne Gee;Eric S. Weintraub;Edward A. Belongia

  • Evaluation of the Association of Maternal Pertussis Vaccination With Obstetric Events and Birth Outcomes

    Elyse O. Kharbanda;Gabriela Vazquez-Benitez;Heather S. Lipkind;Nicola P. Klein

  • Evaluation of the Association of Maternal Pertussis Vaccination With Obstetric Events and Birth Outcomes

    Elyse O. Kharbanda;Gabriela Vazquez-Benitez;Heather S. Lipkind;Nicola P. Klein

  • Smallpox Vaccine: The Good, the Bad, and the Ugly

    Edward A. Belongia;Allison L. Naleway

  • Asthma and farm exposures in a cohort of rural Iowa children.

    James A. Merchant;Allison L. Naleway;Erik R. Svendsen;Kevin M. Kelly

  • Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated — VISION Network, 10 States, December 2021–June 2022

    Unknown

  • Spontaneous Abortion Following COVID-19 Vaccination During Pregnancy.

    Elyse O Kharbanda;Jacob Haapala;Malini DeSilva;Gabriela Vazquez-Benitez

  • Effectiveness of Seasonal Trivalent Influenza Vaccine for Preventing Influenza Virus Illness Among Pregnant Women: A Population-Based Case-Control Study During the 2010–2011 and 2011–2012 Influenza Seasons

    Mark G. Thompson;De-Kun Li;Pat Shifflett;Leslie Z. Sokolow;Leslie Z. Sokolow

  • Delivering Influenza Vaccine to Pregnant Women

    Allison L. Naleway;Wendy J. Smith;John P. Mullooly

  • Influenza Vaccine Effectiveness in Preventing Influenza-associated Hospitalizations During Pregnancy: A Multi-country Retrospective Test Negative Design Study, 2010-2016

    Mark G Thompson;Jeffrey C Kwong;Annette K Regan;Annette K Regan;Mark A Katz;Mark A Katz;Mark A Katz

  • COVID-19 Vaccination Coverage Among Pregnant Women During Pregnancy - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 8, 2021.

    Hilda Razzaghi;Mehreen Meghani;Cassandra Pingali;Bradley Crane

  • A population-based cohort study of undervaccination in 8 managed care organizations across the United States.

    Jason M. Glanz;Sophia R. Newcomer;Komal J. Narwaney;Simon J. Hambidge

  • Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults - Nine States, January-September 2021.

    Peter J Embi;Matthew E Levy;Allison L Naleway;Palak Patel

  • Prevention and Attenuation of COVID-19 by BNT162b2 and mRNA-1273 Vaccines

    Mark G Thompson;Jefferey L Burgess;Allison Naleway;Harmony Tyner

Frequent Co-Authors

Nicola P. Klein
Nicola P. Klein Kaiser Permanente
Mark G. Thompson
Mark G. Thompson Centers for Disease Control and Prevention
Lisa A. Jackson
Lisa A. Jackson Kaiser Permanente
Edward A. Belongia
Edward A. Belongia Marshfield Clinic
Roger Baxter
Roger Baxter Kaiser Permanente
Manjusha Gaglani
Manjusha Gaglani Baylor College of Medicine
Grace M. Lee
Grace M. Lee Stanford University
Steven J. Jacobsen
Steven J. Jacobsen Kaiser Permanente
Frank DeStefano
Frank DeStefano Centers for Disease Control and Prevention
Bruce Fireman
Bruce Fireman Kaiser Permanente

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in microbiology, exploring related online degrees can open diverse career opportunities in healthcare and research. Many students consider programs like an accelerated medical billing and coding certificate online to quickly enter the medical administration field, complementing scientific knowledge with essential healthcare management skills.

Additionally, pursuing various online healthcare degrees that pay well can lead to rewarding jobs that leverage a microbiology background, such as clinical research or public health. For those aiming at public health, identifying the best easiest mph online programs to get into offers flexibility and faster access to advanced roles in epidemiology and health policy.

Moreover, careers like child life specialist blend science with patient care, focusing on the emotional well-being of children in healthcare settings. Learning about child life specialist salary can help gauge the financial prospects of such specialized paths linked to microbiology.

Overall, selecting related online degrees can enhance career versatility, helping microbiology graduates build specialized skills and find meaningful, well-compensated roles in the healthcare landscape.

Best Scientists Citing Allison L. Naleway

Trending Scientists

Recently Published Articles